Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 6/2019

Ausgabe 6/2019

Inhaltsverzeichnis ( 22 Artikel )

18.03.2019 | Original Article | Ausgabe 6/2019

Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling

Jin Gao, Huimin Hu, Xuesong Wang

19.03.2019 | Original Article | Ausgabe 6/2019

d,l-Methadone does not improve radio- and chemotherapy in glioblastoma in vitro

Henry Oppermann, Martina Matusova, Annegret Glasow, Johannes Dietterle, Rainer Baran-Schmidt, Karsten Neumann, Jürgen Meixensberger, Frank Gaunitz

20.03.2019 | Original Article | Ausgabe 6/2019

A phase I study of gemcitabine + dasatinib (gd) or gemcitabine + dasatinib + cetuximab (GDC) in refractory solid tumors

Niharika B. Mettu, Donna Niedzwiecki, Christel Rushing, Andrew B. Nixon, Jingquan Jia, Sherri Haley, Wanda Honeycutt, Herbert Hurwitz, Johanna C. Bendell, Hope Uronis

21.03.2019 | Original Article | Ausgabe 6/2019

Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

Makoto Natsume, Takaya Shimura, Hiroyasu Iwasaki, Yusuke Okuda, Mika Kitagawa, Yasuyuki Okamoto, Kazuki Hayashi, Hiromi Kataoka

25.03.2019 | Original Article | Ausgabe 6/2019

Outcomes of preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer

Takashi Kosaka, Hirotoshi Akiyama, Hiroshi Miyamoto, Sho Sato, Yusaku Tanaka, Kei Sato, Chikara Kunisaki, Itaru Endo

26.03.2019 | Original Article | Ausgabe 6/2019

First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma

Christophe Massard, Jean-Charles Soria, Jürgen Krauss, Michael Gordon, Albert Craig Lockhart, Erik Rasmussen, Vijay V. Upreti, Sonal Patel, Gataree Ngarmchamnanrith, Haby Henary

28.03.2019 | Original Article | Ausgabe 6/2019

LncRNA SNHG16 sponges miR-98-5p to regulate cellular processes in osteosarcoma

Shian Liao, Shuxing Xing, Yanhui Ma

30.03.2019 | Original Article | Ausgabe 6/2019

The combination of olaratumab with gemcitabine and docetaxel arrests a chemotherapy-resistant undifferentiated soft-tissue sarcoma in a patient-derived orthotopic xenograft mouse model

Takashi Higuchi, Kentaro Miyake, Norihiko Sugisawa, Hiromichi Oshiro, Zhiying Zhang, Sahar Razmjooei, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Michael Bouvet, Shree Ram Singh, Hiroyuki Tsuchiya, Robert M. Hoffman

01.04.2019 | Original Article | Ausgabe 6/2019

Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study

Hui Li, Jian Zeng, Xiangyu Jin, Xinmin Yu, Guoming Zhou, Wei Hong

08.04.2019 | Original Article | Ausgabe 6/2019

Comparison of palonosetron and granisetron in triplet antiemetic therapy in nonmetastatic breast cancer patients receiving high emetogenic chemotherapy: a multicenter, prospective, and observational study

Murat Araz, Mustafa Karaagac, Levent Korkmaz, Lokman Koral, Fatih Inci, Ismail Beypinar, Mukremin Uysal, Mehmet Artac

08.04.2019 | Original Article | Ausgabe 6/2019

De-escalated neoadjuvant therapy with nanoparticle albumin-bound paclitaxel and trastuzumab for low-risk pure HER2 breast cancer

Satoru Tanaka, Nobuki Matsunami, Hirotaka Morishima, Naofumi Oda, Tsutomu Takashima, Satoru Noda, Shinichiro Kashiwagi, Yukie Tauchi, Yuka Asano, Kosei Kimura, Hiroya Fujioka, Risa Terasawa, Kanako Kawaguchi, Ayana Ikari, Takashi Morimoto, Shintaro Michishita, Toshihiro Kobayashi, Junna Sakane, Toshikatsu Nitta, Nayuko Sato, Norihiro Hokimoto, Yukihiro Nishida, Mitsuhiko Iwamoto

09.04.2019 | Original Article | Ausgabe 6/2019

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation

Sunil Adige, Rena G. Lapidus, Brandon A. Carter-Cooper, Alison Duffy, Ciera Patzke, Jennie Y. Law, Maria R. Baer, Nicholas P. Ambulos, Ying Zou, Søren M. Bentzen, Ashkan Emadi

10.04.2019 | Original Article | Ausgabe 6/2019

Investigation of anti-tumor effect of doxorubicin-loaded human serum albumin nanoparticles prepared by a desolvation technique

Kotaro Kimura, Keishi Yamasaki, Koji Nishi, Kazuaki Taguchi, Masaki Otagiri

09.04.2019 | Original Article | Ausgabe 6/2019

Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study

Makoto Sakai, Makoto Sohda, Hideyuki Saito, Kengo Kuriyama, Tomonori Yoshida, Yuji Kumakura, Keigo Hara, Takehiko Yokobori, Tatsuya Miyazaki, Kazutoshi Murata, Shin-ei Noda, Takashi Nakano, Hiroyuki Kuwano, Ken Shirabe

09.04.2019 | Original Article | Ausgabe 6/2019

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5′-deoxy-5-fluorocytidine, 5′-deoxy-5-fluorouridine, and 5-fluorouracil

Masae Sekido, Ken-ichi Fujita, Yutaro Kubota, Hiroo Ishida, Takehiro Takahashi, Ryotaro Ohkuma, Takuya Tsunoda, Fumihiro Ishikawa, Motoko Shibanuma, Yasutsuna Sasaki

09.04.2019 | Original Article | Ausgabe 6/2019

Comparison of two different carboplatin and weekly paclitaxel schedule in elderly advanced non-small cell lung cancer patients

Derya Kıvrak Salim, Tuğba Akın Telli, Ali Murat Tatlı, Sadettin Kılıçkap, Perran Fulden Yumuk

11.04.2019 | Original Article | Ausgabe 6/2019 Open Access

Pharmacokinetic and exploratory exposure–response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study

Whitney P. Kirschbrown, Matts Kågedal, Bei Wang, Lars Lindbom, Adam Knott, Rachelle Mack, Sharareh Monemi, Ihsan Nijem, Sandhya Girish, Christie Freeman, Debora Fumagalli, Robin McConnell, Guy Jerusalem, Chris Twelves, José Baselga, Gunter von Minckwitz, José Bines, Amit Garg

11.04.2019 | Original Article | Ausgabe 6/2019 Open Access

Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents

Tim Cardilin, Joachim Almquist, Mats Jirstrand, Astrid Zimmermann, Floriane Lignet, Samer El Bawab, Johan Gabrielsson

29.03.2019 | Clinical Trial Report | Ausgabe 6/2019

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

Fernando Rivera, C. Romero, P. Jimenez-Fonseca, M. Izquierdo-Manuel, A. Salud, E. Martínez, M. Jorge, V. Arrazubi, J. C. Méndez, P. García-Alfonso, M. Reboredo, J. Barriuso, N. Muñoz-Unceta, R. Jimeno, C. López

13.03.2019 | Short Communication | Ausgabe 6/2019 Open Access

Inactivation of apaziquone by haematuria: implications for the design of phase III clinical trials against non-muscle invasive bladder cancer

Roger M. Phillips, Paul M. Loadman, Guru Reddy

13.02.2019 | Short Communication | Ausgabe 6/2019

FLAG vs FLAG-IDA: outcomes in relapsed/refractory acute leukemias

Muhammad Umer Farooq, Fahad Mushtaq, Anum Farooq, Danish Hassan Khan, Muhammad Ayaz Mir

12.03.2019 | Letter to the Editor | Ausgabe 6/2019

Short-time use of crizotinib as neoadjuvant in ALK-positive non-small cell lung carcinoma can be a chance for resectability

Saadettin Kilickap, Sevgen Onder, Omer Dizdar, Mustafa Erman, Aysegul Uner

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise